Literature DB >> 11798182

Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism.

Peter Stoilov1, Eero Castren, Stefan Stamm.   

Abstract

We determined the gene structure of the human TrkB gene. The gene is unusually large and spans at least 590 kbp. It contains 24 exons. Using alternative promoters, splicing, and polyadenylation sites, the gene can create at least 100 isoforms, that can encode 10 proteins. RT-PCR and Northern blot analysis reveals that only three major protein isoforms are generated by the gene: the full length receptor, an isoform lacking the tyrosine kinase domain, and a novel isoform lacking the tyrosine kinase domain but containing a Shc binding site. This novel isoform, TrkB-T-Shc is generated by the use of a new alternative exon 19. It is expressed only in brain. TrkB-T-Shc protein is located in the plasma membrane. Coimmunoprecipitation experiments show that TrkB-T-Shc is not phosphorylated by the full length receptor, indicating that it could be a negative regulator of TrkB signaling in the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11798182     DOI: 10.1006/bbrc.2001.6301

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  56 in total

1.  Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform.

Authors:  Celine Delaloy; Jingyu Lu; Anne-Marie Houot; Sandra Disse-Nicodeme; Jean-Marie Gasc; Pierre Corvol; Xavier Jeunemaitre
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

2.  Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease.

Authors:  Saila Vepsäläinen; Eero Castren; Seppo Helisalmi; Susan Iivonen; Arto Mannermaa; Maarit Lehtovirta; Tuomo Hänninen; Hilkka Soininen; Mikko Hiltunen
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

3.  Nucleotide sequence variation within the human tyrosine kinase B neurotrophin receptor gene: association with antisocial alcohol dependence.

Authors:  K Xu; T R Anderson; K M Neyer; N Lamparella; G Jenkins; Z Zhou; Q Yuan; M Virkkunen; R H Lipsky
Journal:  Pharmacogenomics J       Date:  2007-01-02       Impact factor: 3.550

Review 4.  On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology.

Authors:  Carol J Thiele; Zhijie Li; Amy E McKee
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 5.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

Review 6.  The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development.

Authors:  Mayumi Higashi; Kohei Sakai; Shigehisa Fumino; Shigeyoshi Aoi; Taizo Furukawa; Tatsuro Tajiri
Journal:  Surg Today       Date:  2019-03-08       Impact factor: 2.549

7.  TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation.

Authors:  Zhongkui Li; Zhe Chang; Lucia J Chiao; Ya'an Kang; Qianghua Xia; Cihui Zhu; Jason B Fleming; Douglas B Evans; Paul J Chiao
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

Review 8.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

Review 9.  Brain-derived neurotrophic factor secreted by the cerebral endothelium: A new actor of brain function?

Authors:  Christine Marie; Martin Pedard; Aurore Quirié; Anne Tessier; Philippe Garnier; Perle Totoson; Céline Demougeot
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-20       Impact factor: 6.200

10.  Essential role of Hrs in endocytic recycling of full-length TrkB receptor but not its isoform TrkB.T1.

Authors:  Shu-Hong Huang; Ling Zhao; Zong-Peng Sun; Xue-Zhi Li; Zhao Geng; Kai-Di Zhang; Moses V Chao; Zhe-Yu Chen
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.